R.A. Stahel

Discipline

Psychologie (2)

Type de document

Articles (6) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Patients (4) Mesothelioma (4) Patients (4) oncologie (3) taux (3) survie (3) Treatment (3) Chemotherapy (3) Survival (3) Oncology (3) Human beings (3) Chemotherapy (3) puits (2) thérapie (2) sécurité (2) analyse (2) maladie (2) procès (2) Surgery (2) Inhibitors (2) Ci (Chinese poetry) (2) Therapeutics (2) Theater (2) Surgery (2) Radiotherapy (2) Prognosis (2) Poor (2) Performance (2) Months (2) Lungs (2)

Documents écrit par R.A. Stahel (6) | parle de R.A. Stahel (0)

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
S. Popat et al.
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort.
U. Rulle et al.
Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.
J. Kresoja-Rakic et al. (2017)
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers.
J. Tabernero et al. (2016)
Searching for targets for the systemic therapy of mesothelioma.
R.A. Stahel et al. (2015)
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder et al. (2007)